Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1225 of 3499 entries
View as:

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

Phase: N/A Priority: Normal
NCT ID: NCT04090398 Org: User:
Start: 08/04/20 End: 06/30/26 Due: 06/30/27

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT03258554 Org: User:
Start: 04/03/18 End: 09/19/25 Due: 09/19/26

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Phase: N/A Priority: Normal
NCT ID: NCT00001379 Org: User:
Start: 05/05/95 End: 01/17/25 Due: 01/17/26

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Phase: N/A Priority: Normal
NCT ID: NCT04550494 Org: User:
Start: 04/26/21 End: 12/01/26 Due: 12/01/27

A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners

Phase: N/A Priority: Normal
NCT ID: NCT00342264 Org: User:
Start: 01/12/99 End: 04/16/24 Due: 04/16/25

Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00026104 Org: User:
Start: 11/30/01 End: - Due: -

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03965689 Org: User:
Start: 04/16/20 End: 03/18/26 Due: 03/18/27

Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study

Phase: N/A Priority: Normal
NCT ID: NCT01139476 Org: User:
Start: 06/15/10 End: - Due: -

Psychological Benefits of a Normalized Camping Experience for Children With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00001186 Org: User:
Start: 02/15/83 End: - Due: -

Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study

Phase: N/A Priority: Normal
NCT ID: NCT00100321 Org: User:
Start: 12/21/04 End: 11/20/12 Due: 11/20/13

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Phase: N/A Priority: Normal
NCT ID: NCT00001383 Org: User:
Start: 03/31/94 End: 01/31/01 Due: 01/31/02

Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy

Phase: N/A Priority: Normal
NCT ID: NCT03952598 Org: User:
Start: 10/16/19 End: 12/31/25 Due: 12/31/26

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Phase: N/A Priority: Normal
NCT ID: NCT06498635 Org: User:
Start: 04/01/25 End: 07/15/39 Due: 07/15/40

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04840602 Org: User:
Start: 01/05/22 End: 03/31/28 Due: 03/31/29

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Phase: N/A Priority: Normal
NCT ID: NCT05907759 Org: User:
Start: 07/10/24 End: 12/01/35 Due: 12/01/36

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Phase: N/A Priority: Normal
NCT ID: NCT00092222 Org: User:
Start: 10/28/04 End: 10/01/25 Due: 10/01/26

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03000244 Org: User:
Start: 04/26/17 End: 08/12/50 Due: 08/12/51

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03827343 Org: User:
Start: 01/23/19 End: 12/31/25 Due: 12/31/26

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06995872 Org: User:
Start: 07/02/25 End: 06/01/29 Due: 06/01/30

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05442515 Org: User:
Start: 12/28/22 End: 07/01/29 Due: 07/01/30

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04166409 Org: User:
Start: 01/31/20 End: 12/31/30 Due: 12/31/31

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06672146 Org: User:
Start: 05/16/25 End: 03/31/27 Due: 03/31/28

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00785291 Org: User:
Start: 10/13/08 End: 06/15/17 Due: 06/15/18

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06865664 Org: User:
Start: 07/02/25 End: 04/01/29 Due: 04/01/30

Clinical Genetics Branch Eligibility Screening Survey

Phase: N/A Priority: Normal
NCT ID: NCT07005297 Org: User:
Start: 07/02/25 End: 01/01/36 Due: 01/01/37